Revolution’s New Pancreatic Cancer Drug Doubles Survival Rates
A New Dawn for Pancreatic Cancer: Why the “RAS” Breakthrough Changes Everything For decades, a diagnosis of advanced pancreatic cancer felt like a closing door. With the highest mortality rate among major cancers, the standard of care—chemotherapy—often offered only a grueling path with limited time. However, a major shift is underway. Recent clinical trial data … Read more